sulfo-Cyanine7 amine
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
153C0 | 1 mg | $125 | in stock | |
253C0 | 5 mg | $285 | in stock | |
453C0 | 25 mg | $680 | in stock | |
553C0 | 50 mg | $1260 | in stock | |
653C0 | 100 mg | $1990 | in stock |
Sulfonated amino derivative of Cyanine7 NIR dye.
This NIR dye amine can be used for the derivatization of various targets by the reaction with electrophilic groups, and also by enzymatical reactions involving transamination.
Sulfo-Cyanine7 absorbance and emission spectra
Customers also purchased with this product
Cyanine3 hydrazide
Cyanine3 hydrazide is a carbonyl-reactive dye for Cy3 channel.sulfo-Cyanine5 NHS ester
Water-soluble sulfo-Cyanine5 succinimidyl ester for labeling various amine-containing molecules in the aqueous phase.Cyanine5 azide
Cyanine5 azide is a reagent for click chemistry labeling with Cyanine5, a popular fluorescent dye.
Add this product to your cart and
get free express delivery
get free express delivery
General properties
Appearance: | dark green powder |
Molecular weight: | 807.07 |
CAS number: | 2236573-39-8 |
Molecular formula: | C43H58N4O7S2 |
Solubility: | very poorly soluble in water (0.50 mM = 40 mg/L), good in DMF, DMSO |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. |
MSDS: | Download |
Product specifications |
Spectral properties
Excitation/absorption maximum, nm: | 750 |
ε, L⋅mol−1⋅cm−1: | 240600 |
Emission maximum, nm: | 773 |
Fluorescence quantum yield: | 0.24 |
CF260: | 0.04 |
CF280: | 0.04 |
Product citations
- Grosskopf, A.K.; Correa, S.; Baillet, J.; Maikawa, C.L.; Gale, E.C.; Brown, R.A.; Appel, E.A. Consistent tumorigenesis with self-assembled hydrogels enables high-powered murine cancer studies. Communications Biology, 2021, 4, 985. doi: 10.1038/s42003-021-02500-8
- Kim, H.; Han, J.; Park, J.-H. Cyclodextrin polymer improves atherosclerosis therapy and reduces ototoxicity. Journal of Controlled Release, 2020, 319, 77–86. doi: 10.1016/j.jconrel.2019.12.021
- Rippe, M.; Stefanello, T.F.; Kaplum, V.; Britta, E.A.; Garcia, F.P.; Poirot, R.; Companhoni, M.V.P.; Nakamura, C.V.; Szarpak-Jankowska, A.; Auzély-Velty, R. Heparosan as a potential alternative to hyaluronic acid for the design of biopolymer-based nanovectors for anticancer therapy. Biomaterials Science, 2019, 7, 2850–2860. doi: 10.1039/c9bm00443b
- Guo, X.; Zou, C.-L.; Jung, H.; Gong, Z.; Bruch, A.; Jiang, L.; Tang, H.X. Efficient Generation of a Near-visible Frequency Comb via Cherenkov-like Radiation from a Kerr Microcomb. Physical Review Applied, 2018, 10(1), 014012. doi: 10.1103/PhysRevApplied.10.014012
Cy® is a trademark of GE Healthcare.
Your item has been added.
View your
cart
or
proceed to checkout
The count of items is incorrect.